Novo Nordisk’s (NYSE: NVO) Wegovy pill introduction in the U.S. may serve as the turning point that transforms a beleaguered GLP‑1 leader into a viable 2x story moving forward, provided it effectively ...

Nvidia has unveiled its Vera Rubin compute platform with an architecture designed to power agentic artificial intelligence (AI) systems that think and reason rather than simply retrieve information.

Nvidia Introduces Vera Rubin, a New AI Supercomputing Platform Built to Slash Costs Your email has been sent Nvidia stole the CES spotlight this week with a platform designed to redefine how the world ...

Those who anticipated NVIDIA CEO Jensen Huang would delay delivering an update on its next big AI chip — the Vera Rubin processor first discussed last March at the company’s GTC conference in San Jose ...

The Rubin GPU boasts five times more AI training compute power than Blackwell. The Rubin GPU boasts five times more AI training compute power than Blackwell. is a news writer covering all things ...

A pill form of weight-loss drug Wegovy, manufactured by Danish drugmaker Novo Nordisk, is now available in the U.S., giving Americans access to an oral medication to treat obesity. The starting dose ...

Vera Bradley, the maker of quilted bags and accessories, is changing strategy again following a rebrand that de-emphasized its signature florals and patterns—and left some of its loyal consumers ...

In honor of the holiday, the bridal designer posted a solo photo shoot of herself glammed up in an eye-catching gown with a massive skirt In previous years, Wang has made it a tradition to wear ...

Danish drugmaker Novo Nordisk A/S was at the forefront of the weight-loss injection boom as people discovered that its Ozempic shot, originally developed to treat diabetes, could help trim their ...

Novo Nordisk, which has stumbled through a bit of a manufacturing hangover at a former Catalent production site it picked up a year ago, was hit with a warning letter from the FDA last month. The ...

As both Novo Nordisk and Eli Lilly race to develop their long-anticipated oral GLP-1 obesity meds, a new report shows one taking a clear lead among potential prescribers. Spherix Global Insights ...

When Novo Nordisk launched Wegovy, its pioneering weight-loss jab, in America in June 2021, it felt like it was “running into a dark tunnel”, recalls Maziar Mike Doustdar, who took over as the Danish ...